{
    "2018-05-06": [
        [
            {
                "time": "",
                "original_text": "【高管面对面】7年从200亿到700亿！“民营医药流通第一股”未来还有哪些看点？",
                "features": {
                    "keywords": [
                        "高管",
                        "民营医药流通",
                        "第一股",
                        "7年",
                        "200亿到700亿",
                        "核心竞争力"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "流通"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【采访手记】说一说九州通的核心竞争力",
                "features": {
                    "keywords": [
                        "九州通",
                        "核心竞争力",
                        "医药流通"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "流通"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}